Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Anti-CD19 therapy may help treat SLE and NMOSD.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Baricitinib improved hair loss and arthritis in a lupus patient.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

A patient's grey hair regained color during treatment with adalimumab.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Adalimumab improved folliculitis decalvans in most patients.

Enhancing immune response can improve cancer treatment effectiveness.

Promising cancer treatments were found, but the manufacturer closed.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.